Cost of prostate cancer surgery varies widely in the US

June 18, 2014
Cost of prostate cancer surgery varies widely in the U.S.

(HealthDay)—The open market cost of a radical prostatectomy (RP) varies widely in U.S. hospitals, according to research published in the March issue of Urology.

Scott C. Pate, M.D., of the University of Iowa in Iowa City, and colleagues conducted a of a cohort of 100 U.S. hospitals to solicit price information for RP. The authors used a caller profile of an uninsured 55-year-old man recently diagnosed with Gleason 3 + 4 prostatic adenocarcinoma.

The researchers found that 70 hospitals provided facility prices for RP averaging $34,720 ± 20,335 (range, $10,100 to $135,000). The facility cost for RP was significantly higher at academic centers compared with private hospitals. No significant differences in cost were observed according to region, population, or ranking. Only 10 percent of hospitals provided price information for surgeon and anesthesia fees (average, $8,280 ± 4,282; range, $4,028 to $18,720). Discounts on fees (average, 34 ± 16 percent; range 10 to 80 percent) for prompt payment were offered by 33 hospitals.

"Currently, it appears to be unacceptably difficult for men with prostate cancer without insurance to obtain prices for an RP procedure," the authors write.

Explore further: Surgery prices are elusive: 13-fold price difference among US hospitals for prostate cancer surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Surgery prices are elusive: 13-fold price difference among US hospitals for prostate cancer surgery

June 9, 2014
Let's say you're buying a car. You have a wealth of data at your fingertips, from safety information to performance, to guide your decision.

Prostate cancer surgery better at teaching hospitals

November 7, 2011
Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry ...

Changes in penile length after radical prostatectomy studied

December 16, 2012
(HealthDay)—Although penile shortening of about 1 cm can occur at three months after a radical prostatectomy (RP) for the treatment of localized prostate cancer, recovery of penile length begins after 24 months and is complete ...

Study finds difficulty obtaining pricing, varying costs for total hip replacement

February 11, 2013
Researchers who sought to determine whether pricing information for a total hip replacement could be obtained from hospitals and physicians found getting such information was often difficult and that there were wide variations ...

Thermal sensation spared in nerve-sparing prostatectomy

September 13, 2012
(HealthDay)—Penile thermal sensory thresholds increase after non-nerve-sparing radical prostatectomy (RP) but not after the nerve-sparing procedure, according to a study published in the September issue of The Journal of ...

The role of radical prostatectomy in patients with prostate cancer

February 14, 2013
Even in the presence of screening, there is benefit to radical prostatectomy (RP) in prostate cancer patients, however, the benefit is limited to a subgroup of patients and can take years to become evident according to a ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.